Last reviewed · How we verify
SPARC1104 modified dose regimen III
SPARC1104 is a modified dose regimen of an undisclosed compound, details of which are not publicly available.
At a glance
| Generic name | SPARC1104 modified dose regimen III |
|---|---|
| Sponsor | Sun Pharma Advanced Research Company Limited |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Due to the lack of publicly available information, the exact mechanism of action of SPARC1104 is unknown.
Approved indications
Common side effects
Key clinical trials
- Safety Study of SPARC1104 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |